Our Vision: MicroVention’s goal is to be the leading global neurovascular company. We will accomplish this goal by producing the most reliable, easiest to use and most technologically advanced products supported by proven clinical data.

Internet Explorer users: This website is best viewed with Compatibility Mode disabled. You may need to change your setting to view this site.

 


  • MICROVENTION & SEQUENT MEDICAL
    Terumo Corporation Acquires Sequent Medical: MicroVention Gains Developer of New Aneurysm Embolization Device

  • NEW HEADQUARTERS BUILT BY 2017
    MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo
  • MV Island Booth
    ESMINT 2016 - NICE, FRANCE
    September 8-10, 2016. Come visit us during the meeting.